Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Rheumatology (Oxford, England)|May 29, 2025
An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RPAriane L Herrick, Andrea Murray, Graham Dinsdale, et al.
Journal of Clinical Pharmacology|September 1, 1996
Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curveK Grasing, M G Sturgill, R C Rosen, et al.
The American Journal of Gastroenterology|March 1, 1996
Selective blockade of cholecystokinin type B receptors with L-365,260 does not impair gallbladder contraction in normal humansK Grasing, D Freedholm, M G Murphy, et al.
The Journal of Rheumatology|September 17, 2009
Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosisElena Schiopu, Vivien M Hsu, Ann J Impens, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
Journal of Cardiovascular Pharmacology|June 1, 1997
Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behaviorM G Sturgill, K W Grasing, R C Rosen, et al.
Rheumatology (Oxford, England)|May 15, 2009
The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1Bradley J Rabquer, Yong Hou, Francesco Del Galdo, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
Pageof 18